#CancerTreatmentReviews

Ex vivo drug screening on patient-derived tumor material to advance functional precision in oncology: an overview on current approaches and unresolved challenges Over the past two decades, oncology has undergone a profound transformation, largely driven by the rise of targeted therapies and immune-modulating agents. By tailoring treatments to the molecular pro...

🎄 Festive publication alert from ATTRACT 💫

Our new review in #CancerTreatmentReviews highlights how ex vivo drug screening can support #FunctionalPrecisionOncology and inform #ClinicalTrials like ATTRACT.

doi.org/10.1016/j.ct...

✨ Wishing all a warm and restful holiday season - see you in 2026!

Biomarker-selected or biomarker-agnostic ADCs for oncogene-addicted #NSCLC❓

💡Just out in @myESMO #CancerTreatmentReviews a comprehensive overview on current landscape, challenges and perspectives

Grateful to work with a global amazing team 🙏

Link to the Review:👇
doi.org/10.1016/j.ctrv…